About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Marketing Authorization Application for Boan Biotech's Denosumab Injection Accepted in China

News

- Clinical trials of the drug in Europe and the U.S. are making good progress - Luye Pharma Group announced that the marketing authorization application for the Denosumab Injection (LY06006 / BA6101), developed by Boan Biotech, a subsidiary of ...

October 13,2021

Boan Biotech’s New ADCC-Enhanced Anti-Claudin 18.2 Antibody Drug BA1105 Approved for Clinical Trials in China

Luye Pharma Group today announced that BA1105, a novel antibody developed by its subsidiary Boan Biotech, has been approved by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for clinical ...

October 04,2021

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company